ClinicalTrials.Veeva

Menu

Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression

A

Asan Medical Center

Status

Unknown

Conditions

Suicidal Ideation
Depression

Treatments

Drug: bupropion or lamotrigine

Study type

Observational

Funder types

Other

Identifiers

NCT02428439
S2015-0305-0003

Details and patient eligibility

About

The objective of this study is to identification of genetic markers and predictors of antidepressant-induced suicidality in youth depression. Participants who take the standardized pharmacotherapy (bupropion or lamotrigine) for depression will be observed for 8 weeks. They will do several scales and genetic tests at visit 1 (week 0), visit 3 (week 4) and visit 4 (week 8)

Enrollment

80 estimated patients

Sex

All

Ages

11 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged between 11 and 18 years
  2. Met the Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version (K-SADS-PL) diagnostic criteria for depressive episode or dysthymia
  3. Intelligence quotient higher than 70 on the Korean Educational Developmental Institute's Wechsler Intelligence Scale for Children

Exclusion criteria

  1. presence of intellectual disability
  2. presence of hereditary disorder
  3. past and/or current history of acquired brain injury, like cerebral palsy
  4. presence of seizure, other neurological disorder or sensory impairments
  5. past and/or current history of pervasive developmental disorder
  6. past and/or current history of schizophrenia, bipolar disorder or psychosis
  7. presence of severe learning disorder

Trial design

80 participants in 2 patient groups

Increased suicidality
Description:
Increase in suicidal ideation after taking the standardized pharmacotherapy (bupropion or lamotrigine) during 8 weeks.
Treatment:
Drug: bupropion or lamotrigine
Non-increased suicidality
Description:
Non-increase of suicidal ideation after taking the standardized pharmacotherapy (bupropion or lamotrigine) during 8 weeks.
Treatment:
Drug: bupropion or lamotrigine

Trial contacts and locations

1

Loading...

Central trial contact

Sojung Park, BA; lee myungeun, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems